Intravenous Administration of Functionalized Magnetic Iron Oxide Nanoparticles Does Not Induce CNS Injury in the Rat: Influence of Spinal Cord Trauma and Cerebrolysin Treatment

dc.creatorMenon P.K.
dc.creatorSharma A.
dc.creatorLafuente J.V.
dc.creatorMuresanu D.F.
dc.creatorAguilar Z.P.
dc.creatorWang Y.A.
dc.creatorPatnaik R.
dc.creatorMössler H.
dc.creatorSharma H.S.
dc.date.accessioned2020-09-02T22:22:56Z
dc.date.accessioned2022-11-08T20:20:23Z
dc.date.available2020-09-02T22:22:56Z
dc.date.available2022-11-08T20:20:23Z
dc.date.created2020-09-02T22:22:56Z
dc.date.issued2017
dc.identifier137, , 47-63
dc.identifier00747742
dc.identifierhttps://hdl.handle.net/20.500.12728/5309
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5143569
dc.languageen
dc.publisherAcademic Press Inc.
dc.subjectAdjunct therapy
dc.subjectBlood–brain barrier
dc.subjectCerebrolysin
dc.subjectIron oxide magnetic nanoparticles
dc.subjectNeuroprotection
dc.subjectSpinal cord injury
dc.subjectalbumin
dc.subjectcerebrolysin
dc.subjectglial fibrillary acidic protein
dc.subjectsuperparamagnetic iron oxide nanoparticle
dc.subjectamino acid
dc.subjectcerebrolysin
dc.subjectferric ion
dc.subjectferric oxide
dc.subjectglial fibrillary acidic protein
dc.subjectnanoparticle
dc.subjectneuroprotective agent
dc.subjectalbumin blood level
dc.subjectanimal cell
dc.subjectanimal experiment
dc.subjectanimal model
dc.subjectanimal tissue
dc.subjectastrocyte
dc.subjectblood brain barrier
dc.subjectcell activation
dc.subjectcontrolled study
dc.subjectexperimental CNS injury
dc.subjectimmunohistochemistry
dc.subjectmale
dc.subjectneuroprotection
dc.subjectNissl staining
dc.subjectnonhuman
dc.subjectpriority journal
dc.subjectrat
dc.subjectspinal cord injury
dc.subjectanimal
dc.subjectchemically induced
dc.subjectdisease model
dc.subjectdrug effect
dc.subjectintravenous drug administration
dc.subjectmetabolism
dc.subjectnerve cell
dc.subjectpathology
dc.subjectspinal cord injury
dc.subjectSprague Dawley rat
dc.subjecttreatment outcome
dc.subjectAdministration, Intravenous
dc.subjectAmino Acids
dc.subjectAnimals
dc.subjectDisease Models, Animal
dc.subjectFerric Compounds
dc.subjectGlial Fibrillary Acidic Protein
dc.subjectMale
dc.subjectNanoparticles
dc.subjectNeurons
dc.subjectNeuroprotective Agents
dc.subjectRats
dc.subjectRats, Sprague-Dawley
dc.subjectSpinal Cord Injuries
dc.subjectTreatment Outcome
dc.titleIntravenous Administration of Functionalized Magnetic Iron Oxide Nanoparticles Does Not Induce CNS Injury in the Rat: Influence of Spinal Cord Trauma and Cerebrolysin Treatment
dc.typeBook Chapter


Este ítem pertenece a la siguiente institución